Change in AV-1451 positron emission tomography imaging in patients with Progressive Supranuclear Palsy and Cortico-Basal Syndrome

Trial Profile

Change in AV-1451 positron emission tomography imaging in patients with Progressive Supranuclear Palsy and Cortico-Basal Syndrome

Completed
Phase of Trial: Phase II

Latest Information Update: 16 Jul 2017

At a glance

  • Drugs Flortaucipir-F-18 (Primary)
  • Indications Progressive supranuclear palsy
  • Focus Diagnostic use
  • Most Recent Events

    • 16 Jul 2017 New trial record
    • 08 Jun 2017 Results presented at the 21st International Congress of Parkinson's Disease and Movement Disorders
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top